Antimicrobial resistance has emerged as one of the biggest challenges facing modern medicine, as conventional antibiotics are becoming less effective against many disease-causing bacteria. As a result, researchers around the world are searching for new antibiotics and natural compounds that could help combat drug-resistant microorganisms. Among those contributing to this field is Bangladeshi researcher Dr Khorshed Alam, who has identified potential sources of new natural compounds by analysing the genetic information of microorganisms.
In one of his research projects, he identified 36 potential biosynthetic gene clusters in a bacterial strain, indicating its ability to produce various natural compounds. Two antibiotics, Mycemycin and Mycemycin B, were given particular attention in the study.
Dr Khorshed Alam is currently working at the Chattogram Divisional Office of the Bangladesh Standards and Testing Institution (BSTI). He completed his PhD in Microbiology from the State Key Laboratory of Microbial Technology at Shandong University in China. His research supervisor was renowned molecular scientist Professor Dr Yuming Zhang. Earlier, he completed his bachelor’s and master’s degrees in Microbiology at the University of Chittagong.
His current research focuses primarily on analysing the genetic information of microorganisms to identify natural compounds that could potentially benefit human health.
Recently this correspondent spoke with Dr Khorshed Alam at the BSTI Chattogram office about various aspects of his research.
He explained that one of the significant parts of his research involved a newly identified strain, designated CS-7, belonging to the bacterial genus Streptomyces. The bacterium was isolated from a new source, and its entire genetic information was analysed.
The findings revealed that the bacterium had the potential to produce several types of natural compounds. Researchers therefore examined its genetic information to identify the gene clusters responsible for producing these compounds. The analysis led to the identification of 36 potential gene clusters that could play a role in the production of different natural compounds.
Explaining the process in simple terms, Dr Khorshed Alam said that the genetic information of a bacterium contains instructions that enable it to produce various chemical compounds. Some of these compounds may have the potential to act against disease-causing microorganisms in humans. By analysing genetic information in advance, researchers can identify which bacteria may have the ability to produce potentially useful compounds. His research followed this approach.
In the study of the CS-7 strain, two antibiotics, Mycemycin and Mycemycin B, received particular attention. Their antimicrobial activities were subsequently examined. Their effectiveness was also tested against Staphylococcus aureus, a bacterium that can develop resistance to multiple antibiotics.
The findings of the research were published in the international scientific journal Frontiers in Microbiology.
Another important aspect of the study was not merely identifying potential compounds but also understanding how they are produced. Researchers conducted different analyses to determine which parts of the bacterium’s genetic information were involved in producing particular compounds. Further laboratory investigations were then carried out on the relevant gene clusters. This work opened up possibilities for exploring the use of these natural compounds in future drug development research.
Beyond the Streptomyces study, Dr Khorshed Alam has also conducted research on another bacterial strain, Burkholderia S-53, isolated from a new source.
In this research, the bacterium’s genetic information was analysed to explore its potential to produce new natural compounds. The study sought to identify compounds that could be beneficial to humans and examine whether they might eventually be used in developing medicines. The findings were published in the journal BMC Microbiology.
In another study involving Burkholderia, he identified potential functional gene clusters within the bacterium and explored their prospects for developing new drugs. The research highlighted how the genetic information of microorganisms could be used to discover new natural compounds. Its findings were published in the internationally recognised journal Computers in Biology and Medicine.
He has also conducted research on bacteria belonging to the genus Pseudomonas. The study involved analysing the bacterium’s genetic information to identify its potential to produce different types of natural compounds. Such possibilities within microorganisms could provide opportunities for developing new antimicrobial drugs in the future.
Dr Khorshed Alam has also worked on microorganisms that cannot be grown using conventional laboratory methods. Many microorganisms found in nature cannot be cultivated through standard laboratory techniques, making it difficult to directly examine the beneficial compounds they may contain.
However, analysing their genetic information can provide insights into the compounds they may potentially produce. This approach could create opportunities to identify new drug-development components from microorganisms that are otherwise difficult to study in laboratories.
Alongside research into natural compounds derived from microorganisms, he has also explored genetic approaches to developing new medicines. Once a specific gene cluster is identified in a microorganism, it may be possible to activate it in another suitable microbial host to produce the desired compound.
This approach could eventually help researchers produce larger quantities of compounds that are naturally available only in very small amounts.
He has also conducted a review-based study on triptanthrin, a class of natural compounds. The research examined their different biological activities, natural sources and possible production methods. The findings were also published in an international scientific journal.
Dr Khorshed Alam said the primary objective of his research was not simply to discover new compounds but to explore the vast potential of microorganisms and identify new substances that could contribute to disease prevention and treatment.
The need to discover new compounds is becoming increasingly important, particularly as conventional antibiotics are losing their effectiveness against several disease-causing bacteria.
However, he emphasised that identifying a compound with antimicrobial activity does not automatically make it a new antibiotic suitable for human use. Before any such compound can be used in medical treatment, it must undergo extensive testing to establish its safety, effectiveness, potential side effects and long-term impact on the human body.
Therefore, his research should be viewed as an exploration of potential pathways and candidate compounds for future antibiotic development rather than the discovery of ready-to-use antibiotics.
Despite having several research papers published in international scientific journals, Dr Khorshed Alam’s work has yet to receive significant attention in Bangladesh. Although he has been working for years in the specialised field of identifying new natural compounds through the genetic analysis of microorganisms, his research has remained relatively unfamiliar to many at home.
The researcher considers representing Bangladesh through contributions to international scientific research a matter of personal pride. At the same time, he hopes to encourage young people to pursue research and help create more opportunities for them.
He believes that his research experience could help open up new avenues for microorganism-based drug research in Bangladesh.
Dr Khorshed Alam said Bangladesh needs to expand its research opportunities, particularly by involving young researchers in modern scientific investigations and broadening research on the country’s own microorganisms and biodiversity.
He believes that analysing the genetic information of microorganisms to identify potential ingredients for new medicines could bring significant benefits to the country’s healthcare sector and pharmaceutical industry in the future.

